Navigation Links
Study of placenta unexpectedly leads to cancer gene
Date:12/16/2008

University of Rochester Medical Center scientists discovered a gene mutation that impairs the placenta and also is influential in cancer development, according to a study published online December 16, 2008, in the journal PLoS (Public Library of Science) Biology.

The investigation is the first to link the key placental gene, SENP2, to the well-known p53 protein, which is defective in 50 percent of all cancers.

Until now, the SENP2 gene's role in early embryo development was not known. As a result of making the connection between SENP2 and the potent cancer stimuli, it will be possible to gain more insight into the complex genetic network involved in cancer, and to develop new therapies, said lead author Wei Hsu, Ph.D., associate professor of Biomedical Genetics and Oncology, of the James P. Wilmot Cancer Center.

Hsu and former graduate student Shang-Yi Chiu, currently a postdoctoral fellow at Howard Hughes Medical Institute, Dana-Farber Cancer Institute at Harvard University, have been investigating how cellular signaling triggered by gene mutations affect embryo development in mice. The goal is to better understand the genetic causes and possible treatments for a number of diseases.

"What we discovered was an unexpected interaction between an old player, p53, and a new player, SENP2," said Hsu, who also has an appointment in the URMC Center for Oral Biology.

SENP2 (SUMO-specific protease 2) is highly expressed in trophoblast cells, which are the stem cells required to form the placenta. The placenta surrounds, protects and nourishes the developing fetus. While investigating disruption of placental formation in a mouse model, Hsu's team observed that embryos lacking SENP2 failed to properly make placental tissue.

The failure occurred, researchers discovered, because the cells that give rise to the placental tissues had undergone cell cycle arrest, and were trapped in a state of suspended growth. Nex
'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. New study pardons the misunderstood egg
2. Ocean fish farming harms wild fish, study says
3. Proactive care saves lives of seniors, study finds
4. Orangutans spontaneous whistling opens new chapter in study of evolution of speech
5. First-ever socioeconomic study on coral reefs points to challenges of coastal resource management
6. Study reveals effects of unconscious exposure to advertisements
7. Rice University study finds possible clues to epilepsy, autism
8. Researchers study virus with unusual properties
9. Nanotechnology culture war possible, says Yale study
10. Gene therapy corrects sickle cell disease in laboratory study
11. USC researchers head global effort to study genetic risks that contribute to psychiatric diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Antarctica has long held secrets of the earth,s ...ly, there has been very little information on the ...f ice for millions of years. Now, a team of resear...been funded to the tune of $10 million dollars by ... the bottom of things literally. These scientists...
(Date:11/23/2009)... research presents strong evidence that the "syner...oor traffic-related pollution and indoor endotoxin...the other exposure alone. , Environmental heal... College of Medicine have shown that children expo...es and indoor endotoxin during early life are six ...
(Date:11/23/2009)... by the Wildlife Conservation Society says that we...the Republic of Congopart of the "mother lode" of ... becoming increasingly threatened by growing human... protection of the swamp forests adjacent to the s...recent surveys confirmed that high densities of th...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 1Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients 13118 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 1Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar 28R 29 a New Therapeutic Avenue for the Treatment of Sexual Deviations 4759 3Next Generation Hemostatic Dressing Available for Military Emergencies 52198 1Next Generation Hemostatic Dressing Available for Military Emergencies 52198 2Next Generation Hemostatic Dressing Available for Military Emergencies 52198 3
...e confident, comfortable and flexible with their e...of cardiovascular disease than people who are not....um that helps people understand their eating habit... therapy. , "We wanted to see if people were at h... they were not eating competent to begin with," sa...
...enture capitalist Vinod Khosla told last years Bio...iversity why he believes fuel blends containing 85... supply. , Khosla who last year told The New Yo...in private companies developing ethanol production...al and special interest groups back ethanol, there...
...nstitute of Technology and Emory University have r...ence Foundation to establish "The Origins Project,...public outreach focused on the chemistry that may ...cludes the participation of Spelman College in Atl..., The NSF is supporting The Origins Project as pa...
Other Biology News:Eating competence may lower risk of heart disease 2Iowa State University conference examines developing bioeconomy 2Georgia Tech/Emory Center to study origin of life 2
(Date:11/24/2009)...tario, Nov. 24 Dow AgroS... assets of Hyland Seeds, a division of Thompsons L...d Seeds will further expand Dow AgroSciences, curr...introduction of SmartStax(TM) in 2010 and Do... in corn in 2012. The transactional close is expec...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Sigma-Aldrich Corporation ...OMX conference on Tuesday, December 1st at 1:45 PM... may listen via live audio broadcast over the Inte... a ldrich.com/ . Users can click the "Webcast" ...drich: Sigma-Aldrich is a leading Life Science a...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
(Date:11/24/2009)...ov. 24 NeurogesX, Inc. (...ed on developing and commercializing novel pain ma...iTonno, President and Chief Executive Officer, is ...ray Health Care Conference, to be held December 1-...New York. ,, Mr. DiTonno and Stephen Ghiglieri...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...hnologies announced a new line of genotyping reag...Annual Clinical Virology Symposium in Florida. , ,...r disease in the United States and affects 4 milli...lly, according to a company statement. The new rea...llow labs to develop tests for the six different t...
...s Inc., a provider of services that help small bus...a web-based application that businesses can use to...sends e-mails to business owners reminding them of...s, as well as various meeting deadlines. , ,"Compl...es is often at the bottom of a long list of priori...
...n entrepreneur Ken Schlager started a company, he ...ces. This time around, Schlager is turning to the ...r help as he launches a cutting-edge technology th...eatment. , ,Schlager, a 75-year-old electrical eng...water and removes organic materials, while also di...
Other Biology Technology:CTT - Bridging the states entrepreneurial gap 2CTT - Bridging the states entrepreneurial gap 3
... System provides optimized reagents and protocols ... genes by insertion of group II introns. The metho...rons and utilizes a simple PCR step to re-target t...n into the host genome. Utility of the technology ...
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Biology Products: